Back to Search
Start Over
"The Combination Of Acetyl Leucine And 4-Aminopyridine Or Acetazolamide For Treating Ataxia" in Patent Application Approval Process (USPTO 20230201150).
- Source :
- Drug Week; 7/21/2023, p3215-3215, 1p
- Publication Year :
- 2023
-
Abstract
- "In another aspect, the present disclosure provides the combination of acetyl-leucine and acetazolamide for first line therapy to treat ataxia. "In one aspect, the present disclosure provides acetyl-leucine in combination with acetazolamide for use in the treatment of ataxia in a subject. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15316440
- Database :
- Supplemental Index
- Journal :
- Drug Week
- Publication Type :
- Periodical
- Accession number :
- 164910254